Summary: A precision functional genomics study has mapped when and how a major schizophrenia-associated gene acts during early human brain development. Focusing on ZNF804A—the first risk gene identified from large-scale human genomic studies—researchers pinpointed its peak activity to a critical second-trimester developmental window and traced how disrupting this gene alters neuronal protein synthesis and synaptic excitability.
Using CRISPR-Cas9 gene editing to reduce ZNF804A activity in developing cortical glutamatergic neurons, the team at King’s College London demonstrated a direct mechanistic chain: impaired ZNF804A leads to increased ribosome localization in dendrites, excess local protein translation at synapses, and heightened electrical excitability. These findings translate abstract genetic risk into concrete cellular changes, advancing understanding of schizophrenia biology and highlighting targets for future therapeutic development.
Key Facts
- Bridging genetics and neurobiology: While genomic studies have identified hundreds of loci associated with schizophrenia, they do not indicate when those genes act during development or which cell types they affect. Functional genomics addresses that gap.
- Second-trimester peak activity: ZNF804A is most active early in brain development, consistent with expression patterns observed during the second trimester of human neurodevelopment.
- Cell-type specificity: The gene concentrates its action in cortical glutamatergic neurons during this developmental window, enabling focused study of its cellular roles.
- CRISPR-Cas9 disruption: Researchers used CRISPR-Cas9 to reduce ZNF804A expression in isogenic human induced pluripotent stem cell–derived neurons, modeling a loss of function to reveal downstream effects.
- Increased ribosome localization and local translation: Neurons lacking normal ZNF804A function show abnormal transport of ribosomes into distal dendrites and enhanced local protein synthesis at synapses.
- Synaptic hyper-excitability: Higher levels of synaptic membrane proteins and increased excitatory synapse density produced stronger electrical responses upon chemical stimulation, indicating a hyper-excitable neural state.
Source: King’s College London
Researchers at King’s College London have identified the timing and cellular consequences of altering activity of the schizophrenia-associated gene ZNF804A in developing human cortical neurons.
Schizophrenia is one of the most heritable psychiatric disorders and has a strong developmental component. Large human genomic studies have identified many genetic variants linked to increased schizophrenia risk, but connecting those variants to specific neurobiological mechanisms remains a major challenge. This study makes progress by revealing when ZNF804A acts in development, which cell types it targets, and how its disruption affects synaptic structure and function.
The team generated isogenic human induced pluripotent stem cells with reduced ZNF804A expression and differentiated them into cortical glutamatergic neurons. By combining transcriptomics, compartment‑specific proteomics, high‑content imaging, and functional assays, the researchers traced the consequences of lowering ZNF804A activity during a developmental stage that mirrors the human second trimester.
Microscopy and proteomic analyses showed that neurons with impaired ZNF804A had increased excitatory synapse density and elevated levels of ribosomal and translational proteins in neurites. High‑content imaging confirmed more efficient local protein synthesis at dendritic sites. Functionally, these neurons exhibited greater electrical responses when chemically stimulated, consistent with an increase in synaptic signaling proteins and heightened excitability.
Neurons rely on targeted delivery of ribosomes—the cellular machinery that produces proteins—to dendrites so synapses can generate the proteins they need on site. ZNF804A appears to regulate this process by limiting ribosome localization and local translation at dendritic branch tips. When ZNF804A is disrupted, ribosomes accumulate in distal dendrites, driving excess local protein production and producing hyper‑excitable synapses.
Although ZNF804A was one of the earliest schizophrenia risk genes identified from genomic studies, its cellular role in development was unclear. This work links two previously observed cellular functions—synaptic regulation and control of protein translation—by showing that altered ribosome localization in glutamatergic neurons increases synaptogenesis and excitatory signaling potential.
Professor Deepak Srivastava, joint senior author, emphasized that large genetic studies do not specify when or where a gene acts during development, and that precision functional genomics is needed to map those details. Professor Anthony Vernon, co‑senior author, noted that targeted genetic manipulations are tools to reveal gene‑specific effects at defined developmental time points rather than models of the full genetic risk profile of schizophrenia. The next step is to apply these tools at scale to determine whether diverse schizophrenia risk genes converge on similar pathways and phenotypes.
Funding: This research was supported by the UK Medical Research Council, the Royal Society UK, the Brain & Behavior Foundation, and the National Centre for the Replacement, Refinement and Reduction of Animals in Research.
Key Questions Answered:
A: ZNF804A was the first schizophrenia risk gene identified from genomic data, yet its cellular role was not well understood. By mapping when and where ZNF804A acts and defining its effects on neurons, researchers obtain a concrete mechanistic example that can guide investigations of other risk genes and help reveal convergent biological pathways relevant to schizophrenia.
A: Synapses often form on small dendritic branches where local protein synthesis is required to supply membrane and signaling proteins. ZNF804A normally limits ribosome delivery to these regions. When that control is lost, excess ribosomes produce too many synaptic proteins locally, increasing synapse density and electrical excitability, which can disrupt circuit signaling.
A: No. In this study CRISPR-Cas9 was used as a research tool to reduce gene function and observe consequences during development. ZNF804A acts during fetal brain development, so altering it in adults would not reverse established brain architecture. However, identifying the downstream hyper‑active protein translation pathways provides targets for drug development aimed at normalizing excitability in affected circuits.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The journal paper was reviewed in full.
- Additional context was added by staff.
About this schizophrenia and genetics research news
Author: Franca Davenport
Source: King’s College London
Contact: Franca Davenport – King’s College London
Image: Image credited to Neuroscience News
Original Research: Open access. “Schizophrenia risk gene ZNF804A controls ribosome localization and synaptogenesis in developing human neurons” by Laura Sichlinger et al., published in Science Advances. DOI: 10.1126/sciadv.aea0755
Abstract
Schizophrenia risk gene ZNF804A controls ribosome localization and synaptogenesis in developing human neurons
ZNF804A was among the first genes robustly associated with schizophrenia in large-scale genomic studies. Prior work linked ZNF804A to gene expression regulation and synaptic function, but its role during neurodevelopment and in disease pathogenesis was unclear. To address this, researchers generated isogenic human induced pluripotent stem cells with reduced ZNF804A expression, differentiated them into developing cortical glutamatergic neurons, and examined transcriptomic, synaptic, and proteomic changes.
Mutant neurons showed modest transcriptomic differences but displayed increased excitatory synapse density on high‑content confocal imaging. Compartment‑specific proteomics revealed elevated ribosomal and translational proteins in neurites, and imaging confirmed enhanced local protein synthesis. Together, these data indicate that in developing human cortical glutamatergic neurons, ZNF804A regulates excitatory synapse formation potential by controlling local protein translation.